AXE — Acceleware Income Statement
0.000.00%
Last trade - 00:00
- CA$17.76m
- CA$19.53m
- CA$0.28m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.45 | 0.899 | 0.753 | 0.328 | 0.279 |
Cost of Revenue | |||||
Gross Profit | 1.45 | 0.899 | 0.711 | 0.31 | 0.279 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.96 | 3.02 | 4.8 | 5.54 | 2.25 |
Operating Profit | -1.51 | -2.12 | -4.05 | -5.21 | -1.97 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.56 | -2.1 | -4.08 | -5.14 | -2.05 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.56 | -2.1 | -4.08 | -5.14 | -2.05 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.56 | -2.1 | -4.08 | -5.14 | -2.05 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.56 | -2.1 | -4.08 | -5.14 | -2.05 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.015 | -0.023 | -0.038 | -0.047 | -0.018 |